OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more
OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more
OncoAlert Colloquium Day 4: GI oncology and EONS
OncoAlert Colloquium Day 3: Breast cancer
OncoAlert Colloquium Day 2: Lung cancer and MASCC
OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology
Dihydropyrimidine dehydrogenase polymorphisms knocking on the door
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + trastuzumab for triple-negative disease
Significance of gut microbiota in patients receiving CAR T cell immunotherapy
The RxPONDER trial and its impact on best clinical practice
The global platform for access to childhood cancer medicines
Cancer medicine shortages for children around the world